Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia

Journal of Clinical Oncology

Volumn 11, Issue 9, 1993, Pages 1652-1660

  List, A F ^a   Spier, C ^a   Greer, J ^a   Wolff, S ^a   Hutter, J ^a   Dorr, R ^a   Salmon, S ^a   Futscher, B ^a   Baier, M ^a   Dalton, W ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; CYCLOSPORIN; CYCLOSPORIN A; CYTARABINE; DAUNORUBICIN; DAUNORUBICINOL; GLYCOPROTEIN P; MESSENGER RNA;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER REGRESSION; CHILD; CLINICAL ARTICLE; DOSE RESPONSE; DRUG BLOOD LEVEL; DYSESTHESIA; FEMALE; GENE EXPRESSION; HUMAN; HYPERBILIRUBINEMIA; HYPOMAGNESEMIA; INTRAVENOUS DRUG ADMINISTRATION; MALE; MULTIDRUG RESISTANCE; NAUSEA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; UREMIA; VOMITING;

EID: 0027274736     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1993.11.9.1652     Document Type: Article

References (0)